Trial Profile
Efficacy of pitolisant in patients with refractory partial seizures
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2016
Price :
$35
*
At a glance
- Drugs Pitolisant (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors Bioprojet
- 02 Jun 2016 New trial record
- 25 May 2016 Interim analysis results (n=23) published in the Clinical Neuropharmacology